Moderna price target lowered to $25 from $35 at Wolfe Research
Wolfe Research lowered the firm’s price target on Moderna (MRNA) to $25 from $35 and keeps an Underperform rating on the shares. The firm ...
Trump's reciprocal tariffs could be "big" but "slow" to implement - Wolfe Research
Investing.com - U.S. President Donald Trump's reciprocal tariff policy is likely to face an elongated implementation timeline ...
CVS Health (NYSE:CVS) Price Target Raised to 70.00
CVS Health (NYSE:CVS – Free Report) had its target price increased by Wolfe Research from 67.00 to 70.00 in a report ...
Sumitomo Mitsui Trust Group Inc. Sells 4,683 Shares of Shell plc (NYSE:SHEL)
Sumitomo Mitsui Trust Group Inc. lowered its stake in shares of Shell plc (NYSE:SHEL – Free Report) by 5.2% in the 4th quarter, according to its most recent Form 13F filing with the Securities and ...
Intel set for biggest weekly gain in 40+ years on potential pact with TSMC
Intel (NASDAQ:INTC) shares surged roughly 25% this week and are set for the biggest weekly gain in more than 40 years after ...
NFL on MSN6h
Colleen Wolfe on atmosphere of Philadelphia during Eagles Super Bowl LIX parade
NFL Network's Colleen Wolfe on the atmosphere of Philadelphia during Eagles Super Bowl LIX parade. Yellowstone to Yosemite: ...
Smithsonian Magazine9h
Maned Wolf Program at the National Zoo’s Research Campus Welcomes Three Pups
The three baby wolves were born this winter at the Smithsonian National Zoo’s conservation and research campus in Front Royal ...
A Dividend Giant I’d Buy Over AQN Stock Right Now
AQN stock continues to wrestle with high debt levels and an elevated dividend payout ratio in 2025. This TSX dividend stock is a better buy right now.